Physician profile
Delmon Ashcraft
NPI 1740223635
$2,144.19
in general payments reported to CMS, 2019-2025
24 companies · $321 in 2025
The $321 reported for 2025 was more than what 85% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $389 · 2020: $670 · 2022: $95.92 · 2023: $491 · 2024: $177 · 2025: $321.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $989.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $989.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $860.16 | 2019-2020 | |
| Sumitomo Pharma America, INC. | $262.57 | 2023-2025 | Myfembree, Gemtesa |
| Astellas Pharma US INC | $154.92 | 2022-2025 | Veozah, Myrbetriq |
| Sage Therapeutics, LLC | $133.80 | 2023-2025 | Zurzuvae |
| Abbvie INC. | $84.76 | 2019-2023 | Lo Loestrin Fe, Orilissa, Botox |
| Mayne Pharma Commercial LLC | $82.07 | 2022-2024 | |
| Boston Scientific Corporation | $67.02 | 2020-2024 | Spaceoar Vue System - 10ml |
| Supernus Pharmaceuticals, INC. | $63.42 | 2025 | Qelbree |
| Daiichi Sankyo INC. | $55.30 | 2023-2024 | Injectafer |
| Ethicon US, LLC | $54.83 | 2023 | Stratafix, Dermabond Prineo, Dermabond |
| Exeltis, USA INC. | $49.08 | 2023-2024 | Slynd |
| Conmed Corporation | $44.44 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $40.58 | 2025 | |
| Organon LLC | $34.57 | 2022-2025 | Nexplanon |
| Myovant Sciences INC. | $19.99 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $19.94 | 2025 | Femlyv |
| Coloplast Corp | $17.10 | 2023 | Altis |
| Covidien LP | $16.67 | 2019 | |
| Merck Sharp & Dohme LLC | $16.39 | 2019 | |
| Pfizer INC. | $14.29 | 2025 | |
| Allergan, INC. | $13.88 | 2019 | |
| Exact Sciences Corporation | $13.01 | 2023 | Cologuard Collection Kit |
| Therapeuticsmd, INC. | $12.86 | 2019 | |
| Alexion Pharmaceuticals, INC. | $12.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Delmon Ashcraft listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.